Taiwan Liposome (TLC) Jumps Above 30% as It Attains Approval to Initiate COVID-19 Treatment Trial
Australian and Taiwan approval for TLC19 comes after the acceptance of TLC’s investigational new drug application. Shares of Taiwan Liposome Company Ltd. (TLC) escalates over 31% in today’s trading session. The stock price jumped soon after the company reported that it has obtained the approval in Australia and Taiwan to initiate phase 1 trials of […]